Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2015 1
2018 1
2019 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Dostarlimab as a Miracle Drug: Rising Hope against Cancer Treatment.
Singh V, Sheikh A, Abourehab MAS, Kesharwani P. Singh V, et al. Biosensors (Basel). 2022 Aug 8;12(8):617. doi: 10.3390/bios12080617. Biosensors (Basel). 2022. PMID: 36005013 Free PMC article. Review.
Certain immunotherapies, for example, immune checkpoint inhibitor therapy, monoclonal antibody therapy and chimeric antigen T-cell therapy have garnered extensive interest in response to their exceptional properties that activate the immune system to respond …
Certain immunotherapies, for example, immune checkpoint inhibitor therapy, monoclonal antibody therapy and chimeric antigen T- …
Genetically predicted serum testosterone and risk of gynecological disorders: a Mendelian randomization study.
Zhao B, Wang Z, Liu D, Zhang S. Zhao B, et al. Front Endocrinol (Lausanne). 2023 Nov 21;14:1161356. doi: 10.3389/fendo.2023.1161356. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38075074 Free PMC article.
RESULTS: The results showed that total testosterone and bioavailable testosterone were protective factors for ovarian cancer (odds ratio (OR) = 0.885, P = 0.012; OR = 0.871, P = 0.005) and endometriosis (OR = 0.805, P = 0.020; OR = 0.842, P = 0.028) but were risk fa …
RESULTS: The results showed that total testosterone and bioavailable testosterone were protective factors for ovarian cancer ( …
Management of endometrial, ovarian and cervical cancer in the elderly: current approach to a challenging condition.
Vitale SG, Capriglione S, Zito G, Lopez S, Gulino FA, Di Guardo F, Vitagliano A, Noventa M, La Rosa VL, Sapia F, Valenti G, Rapisarda AMC, Peterlunger I, Rossetti D, Laganà AS. Vitale SG, et al. Arch Gynecol Obstet. 2019 Feb;299(2):299-315. doi: 10.1007/s00404-018-5006-z. Epub 2018 Dec 12. Arch Gynecol Obstet. 2019. PMID: 30542793 Review.
METHODS: We searched MEDLINE (PubMed), EMBASE, Cochrane Central Register of Controlled Trials, IBECS, BIOSIS, Web of Science, SCOPUS and Grey literature (Google Scholar; British Library) from January 1952 to May 2017, using the terms "ovarian cancer", "endometria …
METHODS: We searched MEDLINE (PubMed), EMBASE, Cochrane Central Register of Controlled Trials, IBECS, BIOSIS, Web of Science, SCOPUS and Gre …
Impact of obesity on chemotherapy management and outcomes in women with gynecologic malignancies.
Horowitz NS, Wright AA. Horowitz NS, et al. Gynecol Oncol. 2015 Jul;138(1):201-6. doi: 10.1016/j.ygyno.2015.04.002. Epub 2015 Apr 12. Gynecol Oncol. 2015. PMID: 25870918 Free PMC article. Review.
Search terms included: obesity, overweight, body mass index, body surface area, glomerular filtration rate, chemotherapy, ovarian cancer, endometrial cancer, inflammation, and pharmacokinetics, RESULTS: Obese cancer patients have worse clinical …
Search terms included: obesity, overweight, body mass index, body surface area, glomerular filtration rate, chemotherapy, ovarian …
Oral contraceptive risk assessment: a survey of 247 educated women.
Peipert JF, Gutmann J. Peipert JF, et al. Obstet Gynecol. 1993 Jul;82(1):112-7. Obstet Gynecol. 1993. PMID: 8515909
Between 80-95% of women were unaware of the following health benefits of OCs: decreased risks of endometrial cancer, ovarian cancer, pelvic inflammatory disease, ectopic pregnancy, anemia, and benign breast disease. CONCLUSIONS: Perceptions of the risk …
Between 80-95% of women were unaware of the following health benefits of OCs: decreased risks of endometrial cancer, ovaria …